zolpidem has been researched along with CACH Syndrome in 1 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delorme, C | 1 |
| Adanyeguh, I | 1 |
| Bendetowicz, D | 1 |
| Le Ber, I | 1 |
| Ponchel, A | 1 |
| Kas, A | 1 |
| Habert, MO | 1 |
| Mochel, F | 1 |
1 other study available for zolpidem and CACH Syndrome
| Article | Year |
|---|---|
Multimodal neurometabolic investigation of the effects of zolpidem on leukoencephalopathy-related apathy.
Topics: Adult; Apathy; Brain; Fluorodeoxyglucose F18; Humans; Leukoencephalopathies; Positron-Emission Tomog | 2020 |